SHAWN MOHAMMED: Open Payments
NPI 1265984421 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,845 in 48 payments from 19 companies in 2025. Trend: 2023 $1,881 · 2024 $2,379 · 2025 $1,845
Food & beverage: $1,845
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $340 |
| Alexion Pharmaceuticals, Inc. | 2 | $244 |
| Eisai Inc. | 5 | $243 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Merz Pharmaceuticals, LLC | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $123 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| ACADIA Pharmaceuticals Inc | 1 | $115 |
| Teva Pharmaceuticals USA, Inc. | 1 | $106 |
| UCB, Inc. | 3 | $91 |
Products named: Leqembi, REXULTI, INBRIJA, HYQVIA, Symbravo, ULTOMIRIS, BOTOX, NUPLAZID.
Industry payments across FL — which companies pay providers there.
